BB Biotech AG (BB Biotech AG) Other Liabilities for Banks : $1.64 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is BB Biotech AG Other Liabilities for Banks?

BB Biotech AG's quarterly other liabilities (bank) increased from Jun. 2023 ($3.24 Mil) to Sep. 2023 ($3.30 Mil) but then declined from Sep. 2023 ($3.30 Mil) to Dec. 2023 ($1.64 Mil).

BB Biotech AG's annual other liabilities (bank) declined from Dec. 2021 ($1.59 Mil) to Dec. 2022 ($1.25 Mil) but then increased from Dec. 2022 ($1.25 Mil) to Dec. 2023 ($1.64 Mil).

BB Biotech AG Other Liabilities for Banks Historical Data

The historical data trend for BB Biotech AG's Other Liabilities for Banks can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Other Liabilities for Banks Chart

BB Biotech AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Liabilities for Banks

Get a 7-Day Free Trial

1.47

2.24

1.59

1.25

1.64

BB Biotech AG Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Dec17	Dec18	Dec19	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Liabilities for Banks	Get a 7-Day Free Trial															1.25	4.07	3.24	3.30	1.64

BB Biotech AG Other Liabilities for Banks Calculation

As used by the bank, this category may include numerous accounts not included under other specific liability categories. In some banks, individual accounts are established for control purposes and appear as other liabilities on the balance sheet.

BB Biotech AG (BB Biotech AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (GREY:BBAGF) » Definitions » Other Liabilities for Banks

Comparable Companies

Traded in Other Exchanges

BIONz:UK BBZA:Germany BION:Switzerland

Address

Schwertstrasse 6, Schaffhausen, CHE, CH-8200

Website

https://www.bbbiotech.com

BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

BB Biotech AG (BB Biotech AG) Headlines

No Headlines